Institutional investors purchased a net $22.2 million shares of IMMU during the quarter ended June 2017, and now own 60.49% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VENBIO SELECT ADVISOR LLC Bought 4.3 Million shares of Immunomedics Inc
CREATIVE PLANNING, INC. Bought 1.7 Million shares of Immunomedics Inc
APO ASSET MANAGEMENT GMBH Bought 121.3 Thousand shares of Immunomedics Inc